Prediction of protein-ligand interactions. Docking and scoring: successes and gaps.
By Andrew R. Leach, Brian K. Shoichet, C. E. Peishoff. Journal of Medicinal Chemistry, 2006
621 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Molecular Biology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/bc487d46c377bd963e723e7f1e1889bb2ace1d79
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Stefano Forli
- Brian K. Shoichet
- Sean Ekins
- David S. Goodsell
- Arthur J. Olson
- Jordi Mestres
- Bernard Testa
- F. Silva-Jr
In Molecular Biology
- Stefano Forli
- Brian K. Shoichet
- N. V. Dokholyan
- Sean Ekins
- Shuangye Yin
- John J. Irwin
- Arthur J. Olson
- David S. Goodsell
In Pharmacology
- Brian K. Shoichet
- Sean Ekins
- Jordi Mestres
- Bernard Testa
- John J. Irwin
- F. Silva-Jr
- Paula Jofily
- Pedro H. M. Torres
Citations in the corpus
- Docking & Chemoinformatic Screens for New Ligands and Targets (2009, background): “In the last decade, however, the use of structure-based computational design has made steady, if often unspectacular [2] technical progress, to the point where most pharmaceutical organizations have substantial groups devoted to its application.”
- An interaction-motif-based scoring function for protein-ligand docking (2010, background): “Despite fundamental fallacies in this assumption, it has been adopted for many years, as otherwise the problem would be intractable or too computationally expensive to handle practically [21,22].”
- High quality binding modes in docking ligands to proteins (2008, background): “18–22 Accounting for protein flexibility is a difficult task, due to the huge solution space, with many additional degrees of freedom compared with ligands.”
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling (2007, background): “…in target sites is still a challenging process after more than 20 years of research in the field (Kitchen et al ., 2004; Ghosh et al ., 2006; Leach et al ., 2006) and the performance of different implementations has been found to vary widely depending on the given target (Cummings et al .,…”
- Virtual Screening with AutoDock: Theory and Practice (2010, background): “Building on 2 decades of research, many successful methods for docking of ligands to macromolecular targets have been developed [6-13].”